[Consensus document on treatment of type 2 diabetes in patients with chronic kidney disease].

{"article_title":"[Consensus document on treatment of type 2 diabetes in patients with chronic kidney disease].","author":"G\u00f3mez-Huelgas R, Mart\u00ednez-Castelao A, Artola S, G\u00f3rriz JL, Men\u00e9ndez E","journal_title":"Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","issn":"1989-2284","isbn":"","publication_date":"2021 Mar","volume":"34","issue":"1","first_page":"34","page_count":"","accession_number":"24611186","doi":"","publisher":"Elsevier","doctype":"Consensus Development Conference","subjects":"Diabetes Mellitus, Type 2 complications; Diabetes Mellitus, Type 2 therapy; Diabetic Nephropathies therapy; Renal Insufficiency, Chronic complications; Algorithms; Humans; Hypoglycemic Agents therapeutic use; Risk Factors","interest_area":["Endocrinology"," Internal Medicine"," Urology & Nephrology"],"abstract":"Chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) are highly prevalent chronic diseases that represent a significant public health problem and require multidisciplinary management. T2DM is the main cause of CKD in our setting and it is also a major comorbidity of non-diabetic nephropathy. Patients with diabetes and renal failure represent a special risk group as they have higher morbidity and mortality and are at a higher risk of hypoglycaemia than diabetic individuals with normal renal function. Treatment of T2DM in patients with CKD is controversial because of the scarcity of evidence available. This consensus document aims to facilitate the appropriate selection and dosage of anti-diabetic drugs as well as establishing glycaemic control safety targets in patients with CKD.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=24611186&authtype=shib&custid=ns346513&group=main&profile=eds","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"G\u00f3mez-Huelgas R, Mart\u00ednez-Castelao A, Artola S, G\u00f3rriz JL, Men\u00e9ndez E","Corporate_Authors":"Grupo de Tabajo para el Documento de Consenso sobre el tratamiento de la diabetes tipo 2 en el paciente con enfermedad renal cr\u00f3nica","Journal_Info":"Publisher: Elsevier Country of Publication: Spain NLM ID: 8301215 Publication Model: Print Cited Medium: Internet ISSN: 1989-2284 (Electronic) Linking ISSN: 02116995 NLM ISO Abbreviation: Nefrologia Subsets: MEDLINE","Publication_Type":"Consensus Development Conference; English Abstract; Journal Article; Practice Guideline","Published_Date":"2014-01-01","Source":"Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia [Nefrologia] 2014; Vol. 34 (1), pp. 34-45.","Languages":"Spanish; Castilian","Electronic_ISSN":"1989-2284","MeSH_Terms":"Diabetes Mellitus, Type 2\/*complications , Diabetes Mellitus, Type 2\/*therapy , Diabetic Nephropathies\/*therapy , Renal Insufficiency, Chronic\/*complications, Algorithms ; Humans ; Hypoglycemic Agents\/therapeutic use ; Risk Factors","Subjects":"Algorithms, Humans, Hypoglycemic Agents therapeutic use, Risk Factors, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 therapy, Diabetic Nephropathies therapy, Renal Insufficiency, Chronic complications","Title_Abbreviations":"Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Volume":"34"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"24611186","RelevancyScore":"785","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"785.033752441406"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=24611186&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=24611186&authtype=shib&custid=ns346513&group=main&profile=eds"}